Kłusek, M., Chawrylak, K., Kuszneruk, J., Kubas, M., & Krzemińska, K. (2024). Sodium–glucose co-transporter-2 inhibitors - empagliflozin and dapagliflozin as future therapy for Alport Syndrome, literature review. Quality in Sport, 18, 53252. https://doi.org/10.12775/QS.2024.18.53252